The CancerTYPE ID® test
The CancerTYPE ID® test is a gene expression assay that helps physicians achieve a definitive diagnosis for metastatic patients when the tumor’s origin is uncertain. The test provides increased clarity by helping resolve the following diagnostic dilemmas that impact treatment decisions:
- Unclear/differential diagnoses
- Poorly-differentiated tumors
- Cancers of Unknown Primary (CUP)
- New cancer type vs. recurrence
- Unusual presentations
Visit the full site for more information here.